|
|
|
Insider
Information: |
Schuler Jack W |
Relationship: |
|
City: |
Lake Forest |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
27,956,178 |
|
Indirect Shares
|
61,134,751 |
|
|
Direct
Value |
$207,021,051 |
|
|
Indirect Value
|
$177,439,906 |
|
|
Total
Shares |
89,090,929 |
|
|
Total
Value |
$384,460,957 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
54
|
96
|
Stock
price went up :
|
14
|
2
|
Stock
price went down : |
40
|
94
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-25.7%
|
-5,816.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 17 of 26
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AXDX |
Accelr8 Technology Corp |
Director |
|
2013-08-12 |
4 |
A |
$8.04 |
$5,166,753 |
I/I |
642,631 |
8,685,635 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2013-08-14 |
4 |
B |
$8.04 |
$3,321,244 |
I/I |
413,090 |
9,098,725 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-03-26 |
4 |
B |
$8.04 |
$1,190,217 |
I/I |
148,037 |
13,999,965 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-03-27 |
4 |
B |
$8.09 |
$824,881 |
I/I |
101,963 |
14,101,928 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-03-31 |
4 |
B |
$8.30 |
$996,000 |
I/I |
120,000 |
14,301,928 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-06-05 |
4 |
B |
$8.58 |
$9,438,000 |
I/I |
1,100,000 |
15,963,997 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-03-30 |
4 |
B |
$8.59 |
$687,200 |
I/I |
80,000 |
14,181,928 |
2.25 |
% |
|
VMSI |
Ventana Medical Systems I... |
Director |
|
2006-12-20 |
4/A |
OE |
$8.94 |
$134,070 |
D/D |
15,000 |
2,327,168 |
0 |
- |
|
VMSI |
Ventana Medical Systems I... |
Director |
|
2006-12-20 |
4 |
OE |
$8.94 |
$134,070 |
D/D |
15,000 |
1,239,193 |
0 |
- |
|
VMSI |
Ventana Medical Systems I... |
Director |
|
2008-01-23 |
4 |
OE |
$8.94 |
$7,286,144 |
D/D |
562,666 |
2,806,765 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-04-21 |
4 |
B |
$9.01 |
$717,647 |
I/I |
79,650 |
14,440,935 |
2.25 |
% |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2009-11-04 |
4 |
B |
$9.04 |
$1,808,260 |
D/D |
200,000 |
3,090,890 |
2.45 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-06-05 |
4 |
B |
$9.08 |
$499,173 |
I/I |
54,975 |
54,975 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-06-11 |
4 |
B |
$9.18 |
$1,184,220 |
I/I |
129,000 |
16,373,952 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-05-14 |
4 |
B |
$9.20 |
$272,108 |
I/I |
29,577 |
16,633,101 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-06-12 |
4 |
B |
$9.34 |
$1,252,307 |
I/I |
134,080 |
16,508,032 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-04-20 |
4 |
B |
$9.40 |
$557,956 |
I/I |
59,357 |
14,361,285 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-05-13 |
4 |
B |
$9.46 |
$842,460 |
I/I |
89,055 |
14,863,997 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-04-22 |
4 |
B |
$9.47 |
$1,493,305 |
I/I |
157,688 |
14,598,623 |
2.25 |
% |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2009-11-02 |
4 |
B |
$9.48 |
$40,764 |
D/D |
4,300 |
2,890,890 |
2.37 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-06-09 |
4 |
B |
$9.63 |
$1,742,597 |
I/I |
180,955 |
16,144,952 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-06-10 |
4 |
B |
$9.84 |
$984,000 |
I/I |
100,000 |
16,244,952 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-06-15 |
4 |
B |
$9.86 |
$941,551 |
I/I |
95,492 |
16,603,524 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-05-07 |
4 |
B |
$9.87 |
$246,750 |
I/I |
25,000 |
14,734,942 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-02-02 |
4 |
A |
$9.87 |
$534,283 |
I/I |
54,132 |
1,262,023 |
0 |
- |
|
634 Records found
|
|
Page 17 of 26 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|